Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Peripheral neuropathy as a presenting feature of familial early onset Alzheimer’s disease: a rare clinical association

AI Summary
  • Sensory peripheral neuropathy preceded cognitive decline by almost a decade in a genetically confirmed familial early-onset Alzheimer's patient.
  • Genetic testing identified heterozygous PSEN1 c.349 C>T (p.Pro117Ser) mutation in exon 5 associated with the clinical course.
  • The report emphasises rarity of this association and recommends thorough clinical and electrophysiological evaluation for sensory symptoms in such patients.
Summarise with AI (MRCPsych/FRANZCP)

Acta Neurol Belg. 2026 Jul 10. doi: 10.1007/s13760-026-03142-5. Online ahead of print.

ABSTRACT

We describe a patient with genetically confirmed familial early-onset Alzheimer’s disease in whom sensory peripheral neuropathy preceded cognitive decline by almost a decade. A 40- year- old man presented with clinical and electrophysiological features of sensory neuropathy, and 9 years later developed memory disturbances. Genetic testing revealed a heterozygous PSEN1 c.349 C > T (p. Pro117Ser) mutation in exon 5. To the best of our knowledge, peripheral neuropathy as an initial manifestation of familial early-onset Alzheimer’s disease has never been reported before and could be a possible manifestation of the underlying degenerative process. With this report, we highlight the rarity of this association and underscore the importance of a comprehensive clinical and electrophysiological evaluation in patients with familial early-onset Alzheimer’s disease who present with sensory symptoms, gait disturbances, skin or trophic changes, or other clinical features suggestive of peripheral neuropathy.

PMID:42426493 | DOI:10.1007/s13760-026-03142-5

Document this CPD

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review